Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul F Robbins

Showing results (51-60 of 125) with videos related to

Pageof 13
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapyPaul F Robbins, Mark E Dudley, John Wunderlich, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2012
Epigenetic modulation to enable antigen-specific T-cell therapy of colorectal cancerJeffrey Chou, Lilien N Voong, Christie L Mortales, et al.
Human Gene Therapy|July 9, 2014
A human ErbB2-specific T-cell receptor confers potent antitumor effector functions in genetically engineered primary cytotoxic lymphocytesEvripidis Lanitis, Jenessa B Smith, Denarda Dangaj, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2008
Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapyKhoi Q Tran, Juhua Zhou, Katherine H Durflinger, et al.
Cancer Research|February 12, 2005
Diverse CD8+ T-cell responses to renal cell carcinoma antigens in patients treated with an autologous granulocyte-macrophage colony-stimulating factor gene-transduced renal tumor cell vaccineXianzheng Zhou, Do Youn Jun, Amy Morck Thomas, et al.
Blood|May 5, 2012
Levels of peripheral CD4(+)FoxP3(+) regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancerXin Yao, Mojgan Ahmadzadeh, Yong-Chen Lu, et al.
JCI Insight|October 5, 2018
Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapyRami Yossef, Eric Tran, Drew C Deniger, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2011
An antigenic peptide produced by reverse splicing and double asparagine deamidationAlexandre Dalet, Paul F Robbins, Vincent Stroobant, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2003
High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigensRichard A Morgan, Mark E Dudley, Yik Y L Yu, et al.
Human Gene Therapy|May 6, 2005
Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functionsMarybeth S Hughes, Yik Y L Yu, Mark E Dudley, et al.
Pageof 13

Showing results (51-60 of 125) with videos related to

Sort By:
Pageof 13
Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapyPaul F Robbins, Mark E Dudley, John Wunderlich, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2012
Epigenetic modulation to enable antigen-specific T-cell therapy of colorectal cancerJeffrey Chou, Lilien N Voong, Christie L Mortales, et al.
Human Gene Therapy|July 9, 2014
A human ErbB2-specific T-cell receptor confers potent antitumor effector functions in genetically engineered primary cytotoxic lymphocytesEvripidis Lanitis, Jenessa B Smith, Denarda Dangaj, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2008
Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapyKhoi Q Tran, Juhua Zhou, Katherine H Durflinger, et al.
Cancer Research|February 12, 2005
Diverse CD8+ T-cell responses to renal cell carcinoma antigens in patients treated with an autologous granulocyte-macrophage colony-stimulating factor gene-transduced renal tumor cell vaccineXianzheng Zhou, Do Youn Jun, Amy Morck Thomas, et al.
Blood|May 5, 2012
Levels of peripheral CD4(+)FoxP3(+) regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancerXin Yao, Mojgan Ahmadzadeh, Yong-Chen Lu, et al.
JCI Insight|October 5, 2018
Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapyRami Yossef, Eric Tran, Drew C Deniger, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2011
An antigenic peptide produced by reverse splicing and double asparagine deamidationAlexandre Dalet, Paul F Robbins, Vincent Stroobant, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2003
High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigensRichard A Morgan, Mark E Dudley, Yik Y L Yu, et al.
Human Gene Therapy|May 6, 2005
Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functionsMarybeth S Hughes, Yik Y L Yu, Mark E Dudley, et al.
Pageof 13